Page last updated: 2024-08-18

thiophenes and buprenorphine

thiophenes has been researched along with buprenorphine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Bouvier, M; Bräuner-Osborne, H; Foster, SR; Gabriele, F; Märcher-Rørsted, E; Matosiuk, D; Møller, TC; Pedersen, DS; Pedersen, H; Pedersen, MF; Wróbel, TM	1
Adekoya, P; Gulati, A; Hunter, C; Jones, MR; Kaye, AD; Kaye, AM; Kuppalli, S; Orhurhu, V; Seth, R; Urits, I	1
Banks, ML; Blough, BE; Epstein, DH; Negus, SS; Shaham, Y; Townsend, EA	1

Reviews

1 review(s) available for thiophenes and buprenorphine

Article	Year
Recent Advances in the Treatment of Opioid Use Disorder. Current pain and headache reports, 2021, Mar-11, Volume: 25, Issue:4 Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Implants; Humans; Injections, Intramuscular; Methadone; Molecular Targeted Therapy; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Secologanin Tryptamine Alkaloids; Thiophenes; Urea; Vaccines	2021

Article

Year

Recent Advances in the Treatment of Opioid Use Disorder.

Current pain and headache reports, 2021, Mar-11, Volume: 25, Issue:4

Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Implants; Humans; Injections, Intramuscular; Methadone; Molecular Targeted Therapy; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Secologanin Tryptamine Alkaloids; Thiophenes; Urea; Vaccines

2021

Other Studies

2 other study(ies) available for thiophenes and buprenorphine

Article	Year
Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics. Neuropharmacology, 2020, Volume: 166 Topics: Amino Acid Sequence; Analgesics, Opioid; Buprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; HEK293 Cells; Humans; Kinetics; Morphine; Protein Binding; Receptors, Opioid, mu; Signal Transduction; Spiro Compounds; Thiophenes	2020
Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022, Volume: 47, Issue:12 Topics: Analgesics, Opioid; Animals; Buprenorphine; Fentanyl; Male; Methadone; Narcotics; Opioid-Related Disorders; Rats; Receptors, Opioid; Spiro Compounds; Substance Withdrawal Syndrome; Thiophenes	2022

Article

Year

Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics.

Neuropharmacology, 2020, Volume: 166

Topics: Amino Acid Sequence; Analgesics, Opioid; Buprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; HEK293 Cells; Humans; Kinetics; Morphine; Protein Binding; Receptors, Opioid, mu; Signal Transduction; Spiro Compounds; Thiophenes

2020

Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022, Volume: 47, Issue:12

Topics: Analgesics, Opioid; Animals; Buprenorphine; Fentanyl; Male; Methadone; Narcotics; Opioid-Related Disorders; Rats; Receptors, Opioid; Spiro Compounds; Substance Withdrawal Syndrome; Thiophenes

2022